DHEA in bone and joint diseases

Joint Bone Spine

Volumn 68, Issue 6, 2001, Pages 588-594

  Cormier, Catherine ^a   Souberbielle, Jean Claude ^a   Kahan, André ^a  

^a AP HP ^*  (France)

Author keywords

Bone; Dehydroepiandrosterone; Elderly

Indexed keywords

ESTRADIOL; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; SOMATOMEDIN; TESTOSTERONE;

ADOLESCENT; ADULT; AGED; ARTHROPATHY; BONE DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; SHORT SURVEY; SIDE EFFECT;

EID: 0035673763     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00327-X     Document Type: Short Survey

References (28)

1. An adrenal-secreted androgen dehydroepiandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man
2. Dehydroepiandrosterone and aging
3. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid
4. Regulation of murine lymphokine production in vivo. Dehydroepiandrosterone is a natural enhancer of interleukine 2 synthesis by helper T-cells
5. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: The Rancho Bernardo study
6. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans
7. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease
8. Low dehydroepiandrosterone sulfate and heart disease in middleaged men: Cross-sectional results from the Massachusetts Hale Aging study
9. Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population
10. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: Prospective results from the Massachusetts Male Aging study
11. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
12. Dehydroepiandrosterone replacement in women with adrenal insufficiency
13. Effect of a 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women
14. Dehydroepiandrosterone (DHEA), DHEA sulfate and aging: Contribution of DHEA age study to a socio-biomedical issue
15. Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fractures
16. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study
17. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I and IL-6 levels in women
18. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study
19. Age-related changes in bone turnover in men
20. Changes in quantitative bone histomorphometry in aging healthy men
21. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat
22. Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro
23. 3) to stimulate human osteoblastic cell differenciation
24. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men
25. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women
26. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa
27. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women
28. Dehydroepiandrosterone replacement in women with adrenal insufficiency: Effects on body composition, serum leptin, bone turnover and exercise capacity